Surgery News

Icosapent ethyl demonstrated a very early coronary revascularization benefit, according to findings from REDUCE-IT REVASC.

Available data have shown that CT-derived fractional flow reserve is effective in evaluating CAD and should be integrated into clinical practice, according to a researcher.

CV risk should be comprehensively assessed before noncardiac surgery, including a thorough history and physical examination, researchers found in a review.

Results from the ISCHEMIA trial may lead to increased use of coronary CT angiography to determine risk for events, according to a presentation at Society of Cardiovascular Computed Tomography Annual Scientific Meeting.

The risk for mortality, ACS and major adverse cardio-cerebrovascular events increased throughout 5 years in patients who continued opium consumption after CABG, researchers found.

In a retrospective study of patients with chronic total occlusion and multivessel CAD, CABG conferred better long-term outcomes than PCI, according to data presented at the virtual PCR e-Course.

Edwards Lifesciences announced that the FDA has approved an aortic valve conduit for use during bio-Bentall procedures.

In an analysis of the EUCLID trial, factors associated with major amputation in peripheral artery disease included diabetes, prior amputation, critical limb ischemia and an ankle-brachial index of less than 0.8.

There appears to be no increase in surgeries for congenital heart disease as a result of the 2011 Fukushima Daiichi nuclear accident, researchers reported.

In a meta-analysis of 14 randomized trials of patients with stable ischemic heart disease, revascularization did not reduce risk for mortality but did improve certain other outcomes, researchers reported at the virtual PCR e-Course.